top of page

Scalability

High affordability

Proprietary technology

Agile team

What We Offer

Our proprietary technology is based on the efficient use of novel, GMO-free biocatalytic cascades. We have designed and engineered these pathways to produce nucleotide sugars by magnitude of orders cheaper than the current production costs. Building on that, we are engineering biocatalysts to produce human milk oligosaccharides and tailor the glycosylation of therapeutic proteins.

What we offer
Nucleotide Sugar

Nucleotide Sugars

For applications in R&D, nutrition and pharma. Produced in large scales, available at affordable costs.

Human Milk

Human Milk Oligosaccharides (HMO)

Novel complex human milk oligosaccharides (HMOs) for applications in infant nutrition.

IVG May22.001.png

In Vitro Glycoengineering
(IVGE)

Gain full control over glycosylation with our in-vitro glycosylation toolbox. Scalable to biopharmaceutical production scales.

Our Partners

Logo-BMWi-en-jpeg_edited.png
EXIST-Logo-ohne-unterzeile-fuer-en_edite
Logo-ESF-en_edited.png
logo-eu--en.png
Logo-Zukunft-en-jpeg_edited.png
R_edited.png
mpi+minerva_logo.09_edited.png
mpinnovation
YBE
bottom of page